Tel：
(86)(21)60969600
Add: Building 28, Lane 588, Tianxiong Road. Shanghai, P. R. China
Shanghai, China - On July 28, Shanghai MicroPort EP MedTech Co., Ltd. ("MicroPort EP") received approval notification relating to the quotation of the shares of MicroPort EP on the National Equities Exchange and Quotations ("NEEQ").
MicroPort EP primarily focuses on developing, manufacturing, and marketing of minimally invasive medical devices for the treatment of electrophysiological diseases, such as 3D cardiac mapping system, ablation catheter, and diagnosis catheter. The approval of quotation of MicroPort EP on the NEEQ will enhance its corporate profile, enable it to have a better fund-raising platform, and increase its ability to attract strategic investors.
